Insights

Strategic Partnerships Shionogi has established collaborations with global companies like Apnimed, F2G Ltd., and SUSMED, providing opportunities to offer tailored solutions that enhance their joint development efforts and expand product pipelines in sleep disorders, fungal infections, and dementia support.

Innovation Focus With ongoing development of novel pharmacological therapies for sleep apnea and fungal infections, Shionogi is actively investing in cutting-edge research, creating openings to propose advanced technological tools for R&D, data management, and clinical monitoring.

Data Analytics Upgrade Shionogi's recent partnership with Cloudera to upgrade its data platform highlights a focus on enhancing data analytics capabilities, suggesting a potential opportunity to offer data-driven solutions, cloud analytics, or AI tools to optimize research and operational efficiency.

Expanding COVID-19 Testing The launch of SARS-CoV-2 quantitative testing services indicates Shionogi's active engagement in public health initiatives, opening avenues for providing scalable testing solutions, health data management, or supply chain support in pandemic response efforts.

Market Expansion Potential Operating within the robust Japanese pharmaceutical market and actively investing in product development and innovation, Shionogi offers opportunities for sales of biotech products, digital health tools, R&D support services, and market entry solutions across Asia and beyond.

Similar companies to Shionogi & Co., Ltd

Shionogi & Co., Ltd Tech Stack

Shionogi & Co., Ltd uses 8 technology products and services including Microsoft SharePoint, SQL, Marketo, and more. Explore Shionogi & Co., Ltd's tech stack below.

  • Microsoft SharePoint
    Content Management System
  • SQL
    Database
  • Marketo
    Marketing Automation
  • Microsoft
    Miscellaneous
  • Microsoft Windows
    Operating Systems
  • HTML
    Programming Languages
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics

Media & News

Shionogi & Co., Ltd's Email Address Formats

Shionogi & Co., Ltd uses at least 1 format(s):
Shionogi & Co., Ltd Email FormatsExamplePercentage
First.Last@shionogi.co.jpJohn.Doe@shionogi.co.jp
94%
Last.First@shionogi.co.jpDoe.John@shionogi.co.jp
6%

Frequently Asked Questions

Where is Shionogi & Co., Ltd's headquarters located?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd's main headquarters is located at Japan. The company has employees across 4 continents, including AsiaEuropeNorth America.

What is Shionogi & Co., Ltd's phone number?

Minus sign iconPlus sign icon
You can contact Shionogi & Co., Ltd's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Shionogi & Co., Ltd's stock symbol?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd is a publicly traded company; the company's stock symbol is SGIOY.

What is Shionogi & Co., Ltd's official website and social media links?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd's official website is shionogi.co.jp and has social profiles on LinkedInCrunchbase.

How much revenue does Shionogi & Co., Ltd generate?

Minus sign iconPlus sign icon
As of June 2026, Shionogi & Co., Ltd's annual revenue is estimated to be $2.9B.

What is Shionogi & Co., Ltd's SIC code NAICS code?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Shionogi & Co., Ltd have currently?

Minus sign iconPlus sign icon
As of June 2026, Shionogi & Co., Ltd has approximately 455 employees across 4 continents, including AsiaEuropeNorth America. Key team members include Chief Medical Officer: J. G.Chief Medical Officer: T. D. N.Vice President , Global Medical Science - Virology And Infectious Diseases, Clinical Development: A. H.. Explore Shionogi & Co., Ltd's employee directory with LeadIQ.

What industry does Shionogi & Co., Ltd belong to?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd operates in the Pharmaceutical Manufacturing industry.

What technology does Shionogi & Co., Ltd use?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd's tech stack includes Microsoft SharePointSQLMarketoMicrosoftMicrosoft WindowsHTMLGoogle Tag ManagerGoogle Analytics.

What is Shionogi & Co., Ltd's email format?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd's email format typically follows the pattern of First.Last@shionogi.co.jp. Find more Shionogi & Co., Ltd email formats with LeadIQ.

How much funding has Shionogi & Co., Ltd raised to date?

Minus sign iconPlus sign icon
As of June 2026, Shionogi & Co., Ltd has raised $7.6M in funding. The last funding round occurred on Mar 22, 2018 for $7.6M.

When was Shionogi & Co., Ltd founded?

Minus sign iconPlus sign icon
Shionogi & Co., Ltd was founded in 1878.

Shionogi & Co., Ltd

Pharmaceutical ManufacturingJapan201-500 Employees

Philosophy
The purpose of the Shionogi Group's corporate activities is, as expressed in the opening of its Company Policy, to "supply the best possible medicine to protect the health and wellbeing of the patients we serve." This eternal and unwavering corporate philosophy is a statement of our vision and value to society. To achieve and live by the Company Policy, we have formulated Action Guidelines, which all Shionogi employees share and embrace as norms for daily activities. Through activities based on the Company Policy and the Action Guidelines, Shionogi will continue to contribute to patients, physicians and other healthcare providers, shareholders and investors, and furthermore to society as a whole.

Section iconCompany Overview

Headquarters
Japan
Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
SGIOY
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1878
Employees
201-500

Section iconFunding & Financials

  • $7.6M

    Shionogi & Co., Ltd has raised a total of $7.6M of funding over 1 rounds. Their latest funding round was raised on Mar 22, 2018 in the amount of $7.6M.

  • $1B$10B

    Shionogi & Co., Ltd's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $7.6M

    Shionogi & Co., Ltd has raised a total of $7.6M of funding over 1 rounds. Their latest funding round was raised on Mar 22, 2018 in the amount of $7.6M.

  • $1B$10B

    Shionogi & Co., Ltd's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.